MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1
Open Access
- 1 February 2016
- journal article
- research article
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 38 (2) , 809-820
Abstract
Background/Aims: Postmenopausal osteoporosis is closely associated with reduction in the differentiation of mesenchymal stem cells (MSCs) into osteoblasts. Previous studies have demonstrated that miR-214 plays an important role in the genesis and development of postmenopausal osteoporosis. Here, we performed this study to investigate the potential mechanism by which miR-214 regulates osteoblast differentiation of MSCs. Methods: First, we explored the expression of miR-214 in MSCs of osteoporotic mice. Next, we examined the change of miR-214 during osteoblast differentiation of MSCs. Then, MSCs were infected with lentiviral vectors expressing miR-214 or miR-214 sponge to investigate the effect of miR-214 on osteoblast differentiation of MSCs. Further, bioinformatics analysis and luciferase reporter assay were performed to identify and validate the target gene of miR-214. Results: MiR-214 was up-regulated in MSCs of osteoporotic mice and down-regulated during osteoblast differentiation of MSCs. Furthermore, overexpression of miR-214 inhibited osteoblast differentiation of MSCs in vitro, whereas inhibition of miR-214 function promoted this process, evidenced by increased expression of osteoblast-specific genes, alkaline phosphatase (ALP) activity, and matrix mineralization. Bioinformatics, Western blot analysis and luciferase reporter assay demonstrated that FGFR1 is a direct target of miR-214. Conclusions: MiR-214 attenuates osteogenesis by inhibiting the FGFR1/FGF signaling pathway. Our findings suggest that targeting miR-214 promises to be a potential therapy in treatment of postmenopausal osteoporosis.Keywords
This publication has 34 references indexed in Scilit:
- Fibroblast growth factor (FGF) signaling in development and skeletal diseasesGenes & Diseases, 2014
- Role of miRNAs in bone and their potential as therapeutic targetsCurrent Opinion in Pharmacology, 2014
- MicroRNAs in the control of metastatic bone diseaseTrends in Endocrinology & Metabolism, 2014
- Role of mesenchymal stem cells in bone regeneration and fracture repair: a reviewInternational Orthopaedics, 2013
- MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting OsterixBone, 2013
- Role of FGFs/FGFRs in skeletal development and bone regenerationJournal of Cellular Physiology, 2012
- Dnm3os, a non‐coding RNA, is required for normal growth and skeletal development in miceDevelopmental Dynamics, 2008
- The role of mesenchymal stem cells in maintenance and repair of boneInjury, 2007
- Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signalingJournal of Cellular Biochemistry, 2005
- Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal womenJournal of Cellular Biochemistry, 2004